Clot protection and detection algorithm for activated clotting time testing

US10371694B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10371694-B2
Application numberUS-201615135327-A
CountryUS
Kind codeB2
Filing dateApr 21, 2016
Priority dateDec 6, 2011
Publication dateAug 6, 2019
Grant dateAug 6, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Activated clotting time (ACT) tests detect blood clotting time based on the viscosity changes of a test sample, using a ferromagnetic washer lifted to the top of a test chamber and then dropped from the top via gravity; a drop time greater than a preset threshold value indicates clotting of the test sample. Blood samples which have high levels of heparin usually produce very weak clots that may easily be destroyed by the lifting movement of the washer. But if the clot threshold is set low to detect the weak clots, false detections occur during early testing cycles when activators are not fully suspended during the mixing cycle. Improved algorithms for lifting the washer and adjusting over time enable accurate detection of weak clots.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of detecting formation of a clot in a sample of blood with a ferromagnetic washer moving over a distance through the sample, comprising: a. determining calibration values for at least one of a distance span and a drop velocity of the ferromagnetic washer moving through the sample when the blood is unclotted; b. measuring the distance span or the drop velocity of the ferromagnetic washer moving through the sample; and c. detecting formation of the clot by comparing the value of the distance span or drop velocity measured with the corresponding calibration value. 2. The method of claim 1 , wherein: measuring the distance span or the drop velocity of the ferromagnetic washer moving through the sample is repeated in a plurality of consecutive washer cycles; and detecting formation of the clot is performed in each of the plurality of consecutive washer cycles. 3. The method of claim 1 , in which a calibration value for at least one of a distance span and a drop velocity of the ferromagnetic washer moving through the sample when the blood is unclotted is determined from at least a first pass of the ferromagnetic washer moving through the sample in which only a portion of distance through the sample moved by the ferromagnetic washer is considered, and a second pass in which a fixed time based on only the portion of the distance considered in the first pass is determined.

Assignees

Inventors

Classifications

  • Determining clotting time of blood (by chemical methods G01N33/86, C12Q1/56) · CPC title

  • involving blood coagulating time {or factors, or their receptors} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10371694B2 cover?
Activated clotting time (ACT) tests detect blood clotting time based on the viscosity changes of a test sample, using a ferromagnetic washer lifted to the top of a test chamber and then dropped from the top via gravity; a drop time greater than a preset threshold value indicates clotting of the test sample. Blood samples which have high levels of heparin usually produce very weak clots that may…
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/4905. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).